Hence, studies clarifying the mechanistic actions of miR-143 in modulating NPR3 gene expression may provide an alternative or supplementary approach in developing future HF therapeutics by prolong the half-life of NPs. This evidence concerns the gene NPR3 and hydrops fetalis.